Diabetes Care Devices - Greece

  • Greece
  • Revenue in the Diabetes Care Devices market market in Greece is anticipated to reach US$48.62m in 2024.
  • This revenue is expected to exhibit an annual growth rate (CAGR 2024-2029) of 10.92%, leading to a projected market volume of US$81.64m by 2029.
  • In a global context, the highest revenue will be generated the United States, with an estimated figure of US$11,710.00m in 2024.
  • In Greece, the Diabetes Care Devices market is witnessing a growing demand for advanced technologies, reflecting a heightened awareness of diabetes management among healthcare professionals and patients.

Key regions: Netherlands, Japan, France, Italy, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Diabetes Care Devices Market in Greece is witnessing considerable growth, fueled by increasing prevalence of diabetes, advancements in technology, and heightened awareness about diabetes management among patients and healthcare professionals.

Customer preferences:
Consumers in Greece are increasingly prioritizing personalized diabetes management solutions, prompting a rise in demand for advanced glucose monitoring systems and insulin delivery devices. This shift is influenced by a growing awareness of the importance of tailored treatment plans, driven by cultural factors that emphasize familial support in health management. Additionally, demographic changes, including an aging population and urbanization, are leading to a greater focus on user-friendly technology that integrates seamlessly into daily routines, enhancing adherence to diabetes care.

Trends in the market:
In Greece, the Diabetes Care Devices Market is experiencing a notable shift towards advanced technology solutions, particularly in continuous glucose monitoring systems and smart insulin delivery devices. This trend is driven by an increasing emphasis on personalized care, where patients seek tailored management plans that reflect their unique health profiles. As the population ages and urban lifestyles dominate, there is a heightened demand for intuitive devices that simplify diabetes management. For industry stakeholders, this presents significant opportunities to innovate and develop user-centric products that promote adherence and improve patient outcomes, ultimately transforming diabetes care in Greece.

Local special circumstances:
In Greece, the Diabetes Care Devices Market is significantly influenced by the country's unique geographical and cultural landscape. The prevalence of diabetes among the aging population, combined with a strong family-oriented culture, encourages collaborative health management involving both patients and their families. Additionally, Greece's healthcare system emphasizes public health initiatives, which drive awareness and accessibility to diabetes care solutions. Regulatory support for innovative medical technologies fosters an environment ripe for advancements, making it essential for companies to align their offerings with local healthcare needs and patient preferences.

Underlying macroeconomic factors:
The Diabetes Care Devices Market in Greece is shaped by several macroeconomic factors, including the overall economic stability and growth of the healthcare sector. As Greece continues to recover from previous economic challenges, increased government spending on healthcare and supportive fiscal policies enhance access to diabetes care technologies. Moreover, global trends toward preventive health and chronic disease management are mirrored in Greece, fostering demand for innovative diabetes care solutions. The rising prevalence of diabetes, combined with public health initiatives, further drives investment in medical devices, ensuring that local companies can effectively address the unique healthcare needs of the population.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)